Anti-doping news

PUBLIC DISCLOSURE

IWF reports that the sample of Ms Bilikis Abiodun OTUNLA (NGR) has returned an Adverse Analytical Finding for metenolone and metenolone metabolite -1-methylene-5α-androstane-3α-ol-17-one (S1.1 Anabolic agents). As a consequence, the Athlete is provisionally suspended in view of a potential anti-doping rule violation. In any case, where it is determined that the Athlete did not commit an anti-doping rule violation, the relevant decision will also be published. IWF will not make any further comments on the case until it is

PUBLIC DISCLOSURE

IWF reports that the sample of Mr. Rustam DJANGABAEV (UZB) has returned an Adverse Analytical Finding for Growth Hormone (hGH) (S2. Peptide Hormones, Growth Factors, Related Substances and Mimetics). As a consequence, the Athlete is provisionally suspended in view of a potential anti-doping rule violation. In any case where it is determined that the Athlete did not commit an anti-doping rule violation, the relevant decision will also be published. IWF will not make any further comments on the case until it is

PUBLIC DISCLOSURE

IWF reports that the sample of Ms. Nadezhda LOMOVA (RUS) has returned an Adverse Analytical Finding for metenolone and metenolone metabolite 1-methylene-5α-androstane-3α-ol-17-one (S1.1 Anabolic agents). As a consequence, the Athlete is provisionally suspended in view of a potential anti-doping rule violation. In any case where it is determined that the Athlete did not commit an anti-doping rule violation, the relevant decision will also be published. IWF will not make any further comments on the case until it is

PUBLIC DISCLOSURE

IWF reports that the sample of Mr. Witsanu CHANTRI (THA) has returned an Adverse Analytical Finding for 5a-androstane-3a,17b-diol (5aAdiol) and 5b-androstane-3a,17b-diol (5bAdiol) (S1.1 Anabolic agents). As a consequence, the Athlete is provisionally suspended in view of a potential anti-doping rule violation. In any case where it is determined that the Athlete did not commit an anti-doping rule violation, the relevant decision will also be published. IWF will not make any further comments on the case until it is

PUBLIC DISCLOSURE

The IWF reports that as a consequence of the International Olympic Committee's re-analysis program in connection with the 2012 London Olympic Games, the urine sample of the following Athlete has returned Adverse Analytical Finding: Mr. Florin Ionut CROITORU (ROU) - metabolites of Dehydrochlormethyltestosterone, Metenolone, and Stanozolol (S1.1a Exogenous Anabolic Androgenic Steroids) In line with the respective rules, the IWF imposed mandatory provisional suspensions on the Athlete. The International Olympic Committee is responsible to decide about any consequences relating to the Athletes' participation in the 2012 London Olympic Games. In all cases where it is determined that an Anti-Doping Rule Violation was committed, the responsibility to conduct results management will be transferred to the IWF in terms of consequences extending beyond the Athletes' Olympic Games participation. The IWF will not make any further comments on the case until they are

PUBLIC DISCLOSURE

IWF reports that the sample of Ms. Acchedya JAGADDHITA (INA) has returned an Adverse Analytical Finding for 17β-hydroxymethyl-17α-methyl-18-norandrost-1,4,13-trien-3-one consistent with the administration of the prohibited substance Metandienone (S1.1 Anabolic agents) As a consequence, the Athlete is provisionally suspended in view of a potential anti-doping rule violation. In any case where it is determined that the Athlete did not commit an anti-doping rule violation, the relevant decision will also be published. IWF will not make any further comments on the case until it is